Digital Health Briefs: Stage 3 Meaningful Use; Proteus Digital Health; Google Glass
This article was originally published in The Gray Sheet
Executive Summary
ONC advisory committee approves meaningful use stage 3 recommendations. EU hints at mHealth process progress. Proteus Digital Health Inc. signals expansion to England. More digital health briefs.
You may also be interested in...
Mallinckrodt’s Generics Business Will File For Bankruptcy
Last year, Mallinckrodt attempted restructuring the firm to evade bankruptcy fears. However, the company is now filing for bankruptcy for its US generics business to address “unmanageable liabilities.”
Milan Will Host The Global Generics & Biosimilars Awards 2020
Informa Pharma Intelligence has officially launched the seventh Global Generics & Biosimilars Awards, which will take place in October 2020 in Milan, Italy.
Mylan Weighs In On Coronavirus Drug Shortage Concerns
Hours before the US FDA confirmed the first drug shortage due to active pharmaceutical ingredient constraints because of the coronavirus situation in China, generics industry leader Mylan came under pressure about the potential impact on its business.
Need a specific report? 1000+ reports available
Buy Reports
Register for our free email digests: